X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE MERCK LTD TTK HEALTHCARE/
MERCK LTD
 
P/E (TTM) x 22.8 52.6 43.4% View Chart
P/BV x 7.7 7.9 96.6% View Chart
Dividend Yield % 0.4 0.4 106.4%  

Financials

 TTK HEALTHCARE   MERCK LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
MERCK LTD
Dec-16
TTK HEALTHCARE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs6631,060 62.6%   
Low Rs399623 64.0%   
Sales per share (Unadj.) Rs535.6632.4 84.7%  
Earnings per share (Unadj.) Rs15.945.7 34.9%  
Cash flow per share (Unadj.) Rs20.062.3 32.1%  
Dividends per share (Unadj.) Rs4.0011.00 36.4%  
Dividend yield (eoy) %0.81.3 57.6%  
Book value per share (Unadj.) Rs137.6388.8 35.4%  
Shares outstanding (eoy) m7.7716.60 46.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 74.5%   
Avg P/E ratio x33.318.4 181.0%  
P/CF ratio (eoy) x26.513.5 196.4%  
Price / Book Value ratio x3.92.2 178.4%  
Dividend payout %25.124.1 104.3%   
Avg Mkt Cap Rs m4,12713,969 29.5%   
No. of employees `0001.71.6 107.9%   
Total wages/salary Rs m6071,487 40.8%   
Avg. sales/employee Rs Th2,436.76,631.9 36.7%   
Avg. wages/employee Rs Th355.2939.2 37.8%   
Avg. net profit/employee Rs Th72.5479.4 15.1%   
INCOME DATA
Net Sales Rs m4,16210,498 39.6%  
Other income Rs m61242 25.2%   
Total revenues Rs m4,22310,741 39.3%   
Gross profit Rs m1971,135 17.4%  
Depreciation Rs m32276 11.5%   
Interest Rs m300-   
Profit before tax Rs m1971,102 17.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73343 21.2%   
Profit after tax Rs m124759 16.3%  
Gross profit margin %4.710.8 43.8%  
Effective tax rate %37.031.1 118.8%   
Net profit margin %3.07.2 41.2%  
BALANCE SHEET DATA
Current assets Rs m1,6296,410 25.4%   
Current liabilities Rs m1,0588,828 12.0%   
Net working cap to sales %13.7-23.0 -59.5%  
Current ratio x1.50.7 212.1%  
Inventory Days Days3058 51.6%  
Debtors Days Days3438 87.5%  
Net fixed assets Rs m5561,406 39.6%   
Share capital Rs m78166 46.8%   
"Free" reserves Rs m8786,286 14.0%   
Net worth Rs m1,0696,455 16.6%   
Long term debt Rs m1590-   
Total assets Rs m2,3998,828 27.2%  
Interest coverage x7.6NM-  
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.2 145.9%   
Return on assets %6.48.6 74.6%  
Return on equity %11.611.8 98.5%  
Return on capital %18.517.1 108.1%  
Exports to sales %0.88.3 9.5%   
Imports to sales %1.421.0 6.7%   
Exports (fob) Rs m33869 3.8%   
Imports (cif) Rs m582,209 2.6%   
Fx inflow Rs m33959 3.4%   
Fx outflow Rs m632,612 2.4%   
Net fx Rs m-30-1,653 1.8%   
CASH FLOW
From Operations Rs m1271,070 11.8%  
From Investments Rs m-146-750 19.5%  
From Financial Activity Rs m22-150 -14.6%  
Net Cashflow Rs m3171 1.5%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.7 18.2 20.3%  
FIIs % 5.2 1.0 520.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 29.1 88.7%  
Shareholders   12,723 28,591 44.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 18, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS